HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients.

Abstract
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
AuthorsBrian Ayers, Katherine Wood, Jennifer Falvey, Wendy Bernstein, Igor Gosev
JournalClinical case reports (Clin Case Rep) Vol. 8 Issue 9 Pg. 1722-1727 (Sep 2020) ISSN: 2050-0904 [Print] England
PMID32983485 (Publication Type: Case Reports)
Copyright© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: